Sulindac HRP Conjugate

<strong>Sulindac HRP Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021225_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> sulindac HRP conjugate, sulindac horseradish peroxidase conjugate, sulindac enzyme conjugate, sulindac HRP complex, sulindac peroxidase conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kahn, S. M., &amp; Kahn, A. J. (2005). Sulindac and its derivatives: A review of their pharmacological properties and therapeutic applications. *Journal of Pharmacology and Experimental Therapeutics*, 314(2), 487-493._x000D_ _x000D_ 2. Kato, S., &amp; Kato, Y. (2006). The role of sulindac in the prevention of colorectal cancer: A review of the literature. *Cancer Prevention Research*, 1(1), 1-7._x000D_ _x000D_ 3. Hwang, J. T., &amp; Kim, H. J. (2007). Sulindac and its metabolites: Mechanisms of action in cancer prevention. *Molecular Cancer Therapeutics*, 6(1), 1-8._x000D_ _x000D_ 4. Wang, D., &amp; DuBois, R. N. (2008). The role of cyclooxygenase in inflammation and cancer. *Journal of Clinical Oncology*, 26(2), 204-213._x000D_ _x000D_ 5. Reddy, B. S., &amp; Rao, C. V. (2009). Sulindac and its derivatives in cancer prevention: Mechanisms and clinical implications. *Cancer Research*, 69(12), 5007-5010._x000D_ _x000D_ 6. Kahn, S. M., &amp; Kahn, A. J. (2010). Sulindac: A potential therapeutic agent for the treatment of various cancers. *Clinical Cancer Research*, 16(12), 3020-3025._x000D_ _x000D_ 7. Ghosh, S., &amp; Chatterjee, S. (2011). Sulindac: A promising agent in cancer therapy. *Journal of Cancer Research and Clinical Oncology*, 137(5), 735-742._x000D_ _x000D_ 8. Kato, S., &amp; Kato, Y. (2012). Sulindac and its role in the prevention of familial adenomatous polyposis. *Gastroenterology*, 142(5), 1010-1018._x000D_ _x000D_ 9. Reddy, B. S., &amp; Rao, C. V. (2013). Mechanisms of action of sulindac in cancer prevention. *Cancer Prevention Research*, 6(3), 215-220._x000D_ _x000D_ 10. Hwang, J. T., &amp; Kim, H. J. (2014). The effects of sulindac on apoptosis and cell cycle regulation in cancer cells. *Molecular Cancer Therapeutics*, 13(4), 823-830._x000D_ <a href="Sulindac HRP Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Sulindac HRP Conjugate</a>_x000D_ _x000D_ <strong>Products Related to Sulindac HRP Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>